70 likes | 81 Views
Type 2 Diabetes Market is expected to grow at a significant rate during the forecast period 2018-2023. Type 2 diabetes is a long-term disorder characterized by the resistance of the insulin and relative shortage of insulin. Increased dehydration, sudden weight loss, and frequent urination are some of the symptoms of type 2 diabetes. Type 2 diabetes occurs mainly due to obesity and lack of exercise. However, it is preventable partly by eating properly, maintaining a normal weight, and exercising regularly.<br>
E N D
Type 2 Diabetes Treatment Market
Definition: Type 2 diabetes is a long-term disorder characterized by the resistance of the insulin and relative shortage of insulin.
Motivators Increasing Prevalence of Type 2 Diabetes Rising Demand for Non-Invasive Monitoring Devices Increasing Government Initiatives Rising Obesity Coupled with Change in Lifestyle
Market Segmentation: Global Type 2 Diabetes Market by Devices Insulin Pumps:45% Insulin Pen:20% Blood Glucose Meters:30% Others:5%
Region Covered: North America:35% Europe:30% Asia-Pacific:20%A Rest of the World:15%
Market Players: • Abbott Laboratories, Inc. • AstraZeneca, PLC • Bayer AG • Becton, Dickinson and Co. • Eli Lilly and Co. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline, PLC • Johnson And Johnson Services, Inc.
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global)305 – 308 Commerce House, Janjeerwala Square Indore, Madhya Pradesh India- 452001 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com